The Tmp Gene, Encoding a Membrane Protein, Is a c-Myc Target with a Tumorigenic Activity

REFERENCES

• Auvinen, M., A. Laine, A. Paasinen-Sohns, A. Kangas, L. Kangas, O. Saksela, L. C. Andersson, and J. Holtta 1997. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res. 57:3016–3025.
   PubMed Web of Science ®Google Scholar
• Auvinen, M., A. Paasinen, L. C. Andersson, and J. Holtta 1992. Ornithine decarboxylase activity is critical for cell transformation. Nature 360:355–358.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., L. Kretzner, and J. Eisenman 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211–222.
   PubMed Web of Science ®Google Scholar
• Bello-Fernandez, C., G. Packham, and J. Cleveland 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804–7808.
   PubMed Web of Science ®Google Scholar
• Ben-Porath, I., and J. Benvenisty 1996. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins. Gene 183:69–75.
   PubMed Web of Science ®Google Scholar
• Ben-Porath, I., C. A. Kozak, and J. Benvenisty 1998. Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics 49:443–447.
   PubMed Web of Science ®Google Scholar
• Benvenisty, N., A. Leder, A. Kuo, and J. Leder 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513–2523.
   PubMedGoogle Scholar
• Benvenisty, N., D. M. Ornitz, G. L. Bennett, B. G. Sahagan, A. Kuo, R. D. Cardiff, and J. Leder 1992. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Oncogene 7:2399–2405.
   PubMedGoogle Scholar
• Ben-Yosef, T., O. Yanuka, and J. Benvenisty 1996. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast. Oncogene 13:1859–1866.
   PubMed Web of Science ®Google Scholar
• Blackwell, T., J. Huang, A. Ma, L. Kretzner, F. Alt, R. Eisenman, and J. Weintraub 1993. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13:5216–5224.
   PubMed Web of Science ®Google Scholar
• Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and J. Weintraub 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149–1151.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and J. Eisenman 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.
   PubMed Web of Science ®Google Scholar
• Bolin, L., T. McNeil, L. Lucian, B. DeVaux, K. Franz-Bacon, D. Gorman, S. Zurawski, R. Murray, and J. McClanahan 1997. HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural development and injury. J. Neurosci. 17:5493–5502.
   PubMed Web of Science ®Google Scholar
• Cardiff, R., A. Leder, A. Kuo, P. Pattengale, and J. Leder 1993. Multiple tumor types appear in a transgenic mouse with the ras oncogene. Am. J. Pathol. 142:1199–1207.
   PubMedGoogle Scholar
• Cavalieri, F., and J. Goldfarb 1987. Growth factor-deprived BALB/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression. Mol. Cell. Biol. 7:3554–3560.
   PubMed Web of Science ®Google Scholar
• Chance, P. F., and J. Fischbeck 1994. Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies. Hum. Mol. Genet. 3:1503–1507.
   PubMed Web of Science ®Google Scholar
• Chen, C., and J. Okayama 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and J. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
   PubMed Web of Science ®Google Scholar
• Corden, J., B. Wasylyk, A. Buchwalder, C. P. Sassone, C. Kedinger, and J. Chambon 1980. Promoter sequences of eukaryotic protein-coding genes. Science 209:1406–1414.
   PubMed Web of Science ®Google Scholar
• Cox, A., and J. Der 1994. Biological assays for cellular transformation. Methods Enzymol. 238:277–294.
   PubMedGoogle Scholar
• Dang, C. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1–11.
   PubMed Web of Science ®Google Scholar
• Davis, L., and J. Halazonetis 1993. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max. Oncogene 8:125–132.
   PubMedGoogle Scholar
• Eden, A., G. Simchen, and J. Benvenisty 1996. Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J. Biol. Chem. 271:20242–20245.
   PubMed Web of Science ®Google Scholar
• Eilers, M., D. Picard, K. R. Yamamoto, and J. Bishop 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66–68.
   PubMedGoogle Scholar
• Elson, A., C. Deng, J. Campos-Torres, L. Donehower, and J. Leder 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11:181–190.
   PubMed Web of Science ®Google Scholar
• Elson, A., and J. Leder 1995. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras or neu. J. Biol. Chem. 270:26116–26122.
   PubMedGoogle Scholar
• Evan, G., E. Harrington, A. Fanidi, H. Land, B. Amati, and J. Bennett 1994. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345:269–275.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and J. Hancock 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119–128.
   PubMed Web of Science ®Google Scholar
• Fabbretti, E., P. Edomi, C. Brancolini, and J. Schneider 1995. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9:1846–1856.
   PubMed Web of Science ®Google Scholar
• Facchini, L. M., and J. Penn 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12:633–651.
   PubMed Web of Science ®Google Scholar
• Galaktionov, K., X. Chen, and J. Beach 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511–517.
   PubMed Web of Science ®Google Scholar
• Galaktionov, K., A. K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and J. Beach 1995. CDC25 phosphatases as potential human oncogenes. Science 269:1575–1577.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and J. Howard 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Grandori, C., and J. Eisenman 1997. Myc target genes. Trends Biochem. Sci. 22:177–181.
   PubMed Web of Science ®Google Scholar
• Grandori, C., J. Mac, F. Siebelt, D. Ayer, and J. Eisenman 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344–4357.
   PubMed Web of Science ®Google Scholar
• Iyer, V., and J. Struhl 1995. Poly(dA:dT), a ubiquitous promoter element that stimulates transcription via its intrinsic DNA structure. EMBO J. 14:2570–2579.
   PubMed Web of Science ®Google Scholar
• Keath, E. J., P. G. Caimi, and J. Cole 1984. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 39:339–348.
   PubMed Web of Science ®Google Scholar
• Kelekar, A., and J. Cole 1986. Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes. Mol. Cell. Biol. 6:7–14.
   PubMed Web of Science ®Google Scholar
• Krane, I., and J. Leder 1996. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12:1781–1788.
   PubMedGoogle Scholar
• Lazaris-Karatzas, A., K. Montine, and J. Sonenberg 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544–547.
   PubMed Web of Science ®Google Scholar
• Lee, W., A. Haslinger, M. Karin, and J. Tjian 1987. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325:368–372.
   PubMed Web of Science ®Google Scholar
• Littlewood, T., D. Hancock, P. Danielian, M. Parker, and J. Evan 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686–1690.
   PubMed Web of Science ®Google Scholar
• Lobsiger, C., J. Magyar, V. Taylor, P. Wulf, A. Welcher Amgen EST Program, U. Suter 1996. Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1. Genomics 36:379–387.
   PubMedGoogle Scholar
• Manfioletti, G., M. E. Ruaro, G. Del Sal, L. Philipson, and J. Schneider 1990. A growth arrest-specific (gas) gene codes for a membrane protein. Mol. Cell. Biol. 10:2924–2930.
   PubMedGoogle Scholar
• Marcu, K. B., S. A. Bossone, and J. Patel 1992. myc function and regulation. Annu. Rev. Biochem. 61:809–860.
   PubMed Web of Science ®Google Scholar
• Marhin, W., S. Chen, L. Facchini, J. Fornace, and J. Penn 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825–2834.
   PubMedGoogle Scholar
• Marvin, K. W., W. Fujimoto, and J. Jetten 1995. Identification and characterization of a novel squamous cell-associated gene related to PMP22. J. Biol. Chem. 270:28910–28916.
   PubMed Web of Science ®Google Scholar
• Meichle, A., A. Philipp, and J. Eilers 1992. The functions of Myc proteins. Biochim. Biophys. Acta 1114:129–146.
   PubMedGoogle Scholar
• Miltenberger, R., K. Sukow, and J. Farnham 1995. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527–2535.
   PubMed Web of Science ®Google Scholar
• Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and J. Leder 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115.
   PubMed Web of Science ®Google Scholar
• Patel, P. I., and J. Lupski 1994. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet. 10:128–133.
   PubMedGoogle Scholar
• Pena, A., C. D. Reddy, S. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and J. Soprano 1993. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J. Biol. Chem. 268:27277–27285.
   PubMedGoogle Scholar
• Potter, H., L. Weir, and J. Leder 1984. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81:7161–7165.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., and J. Ziff 1992. A new bind for Myc. Trends Genet. 8:91–96.
   PubMedGoogle Scholar
• Ray, R., S. Thomas, and J. Miller 1989. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice. Oncogene 4:593–600.
   PubMedGoogle Scholar
• Reisman, D., N. B. Elkind, B. Roy, J. Beamon, and J. Rotter 1993. c-Myc transactivates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4:57–65.
   PubMedGoogle Scholar
• Ruegg, C. L., H. Y. Wu, F. F. Fagnoni, E. G. Engleman, and J. Laus 1996. B4B, a novel growth-arrest gene, is expressed by a subset of progenitor/pre-B lymphocytes negative for cytoplasmic mu-chain. J. Immunol. 157:72–80.
   PubMedGoogle Scholar
• Sambrook, J., E. F. Fritsch, T. Maniatis 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Schiemann, S., M. Ruckels, L. H. Engelholm, M. Schwirzke, N. Brunner, and J. Weidle 1997. Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family. Anticancer Res. 17:13–20.
   PubMedGoogle Scholar
• Shim, H., C. Dolde, B. C. Lewis, C. S. Wu, G. Dang, R. A. Jungmann, R. Dalla-Favera, and J. Dang 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94:6658–6663.
   PubMed Web of Science ®Google Scholar
• Small, M. B., N. Hay, M. Schwab, and J. Bishop 1987. Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol. 7:1638–1645.
   PubMed Web of Science ®Google Scholar
• Snipes, G. J., U. Suter, and J. Shooter 1993. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 61:1961–1964.
   PubMed Web of Science ®Google Scholar
• Stewart, T. A., P. K. Pattengale, and J. Leder 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627–637.
   PubMed Web of Science ®Google Scholar
• Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and J. Lee 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697–1709.
   PubMed Web of Science ®Google Scholar
• Suter, U., and J. Snipes 1995. Peripheral myelin protein 22: facts and hypotheses. J. Neurosci. Res. 40:145–151.
   PubMedGoogle Scholar
• Suter, U., G. J. Snipes, S. R. Schoener, A. A. Welcher, S. Pareek, J. R. Lupski, R. A. Murphy, E. M. Shooter, and J. Patel 1994. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem. 269:25795–25808.
   PubMedGoogle Scholar
• Tavtigian, S. V., S. D. Zabludoff, and J. Wold 1994. Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Mol. Biol. Cell 5:375–388.
   PubMedGoogle Scholar
• Taylor, V., and J. Suter 1996. Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene 175:115–120.
   PubMed Web of Science ®Google Scholar
• Taylor, V., A. A. Welcher Amgen EST Program, U. Suter 1995. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J. Biol. Chem. 270:28824–28833.
   PubMed Web of Science ®Google Scholar
• Wagner, A. J., C. Meyers, L. A. Laimins, and J. Hay 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879–883.
   PubMedGoogle Scholar
• Wulf, G., C. Adra, and J. Lim 1993. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA. EMBO J. 12:5065–5074.
   PubMed Web of Science ®Google Scholar
• Yang, W., H. Wang, and J. Fliegel 1996. Regulation of Na+/H+ exchanger gene expression. Role of a novel poly(dA · dT) element in regulation of the NHE1 promoter. J. Biol. Chem. 271:20444–20449.
   PubMedGoogle Scholar
• Zoidl, G., K. S. Blass, D. D’Urso, C. Schmalenbach, and J. Muller 1995. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J. 14:1122–1128.
   PubMedGoogle Scholar
• Zoidl, G., D. D’Urso, K. S. Blass, C. Schmalenbach, R. Kuhn, and J. Muller 1997. Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22Trembler on cell growth of NIH3T3 fibroblasts. Cell Tissue Res. 287:459–470.
   PubMedGoogle Scholar